Effect of extracorporeal photopheresis on survival in acute graft versus host disease
Background Extracorporeal photopheresis (ECP) is the main non‐pharmacological
approach accompanying systemic medical treatments in steroid‐resistant acute or chronic …
approach accompanying systemic medical treatments in steroid‐resistant acute or chronic …
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
E Bisaccia, M Palangio, J Gonzalez, KR Adler… - Bone marrow …, 2003 - nature.com
Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy,
has previously demonstrated promising results in treating chronic graft-versus-host disease …
has previously demonstrated promising results in treating chronic graft-versus-host disease …
Extracorporeal photopheresis, the Dutch experience
O Visser, MCE Schoordijk - Transfusion and Apheresis Science, 2013 - Elsevier
Graft-versus-Host Disease (GVHD) is the primary cause of late morbidity and mortality after
allogeneic stem cell transplantation (SCT). In chronic GVHD (cGVHD), often multiple organ …
allogeneic stem cell transplantation (SCT). In chronic GVHD (cGVHD), often multiple organ …
[HTML][HTML] Extracorporeal photopheresis as graft-versus-host disease prophylaxis: a randomized controlled trial
MM Ali, T Gedde-Dahl, LT Osnes, F Perrier… - … and Cellular Therapy, 2023 - Elsevier
Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only
curative option for many patients diagnosed with hematological malignancies. A major …
curative option for many patients diagnosed with hematological malignancies. A major …
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and …
FM Foss, GM DiVenuti, K Chin, K Sprague… - Bone marrow …, 2005 - nature.com
We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …
Extracorporeal photochemotherapy for the treatment of graft‐versus‐host disease
R Dall'Amico, C Messina - Therapeutic Apheresis, 2002 - Wiley Online Library
Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …
photochemotherapy used for the treatment of oncological and autoimmune diseases …
Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
G Afram, E Watz, M Remberger, UA Nygell… - … European Journal of …, 2019 - termedia.pl
Results Compared to the control group and the stable/progressive disease (SD/PD) patients,
individuals with complete/partial remission have higher overall survival and lower transplant …
individuals with complete/partial remission have higher overall survival and lower transplant …
Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with …
SM Linn, I Novitzky-Basso, C Patriquin, I Pasic… - Leukemia Research, 2023 - Elsevier
Background Extracorporeal photopheresis (ECP) is recommended as a second-or later-line
therapy for chronic GvHD (cGvHD). Benefits include reasonable response with avoidance of …
therapy for chronic GvHD (cGvHD). Benefits include reasonable response with avoidance of …
Care of patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence
P Woltz, K Castro, BJ Park - Clinical Journal of Oncology …, 2006 - search.proquest.com
Late immune dysregulation following allogeneic hematopoietic cell transplantation (HCT) is
known as chronic graft-versus-host disease (GVHD), which is a major cause of mortality and …
known as chronic graft-versus-host disease (GVHD), which is a major cause of mortality and …
Peri-transplant extracorporeal photopheresis to mitigate GVHD-a pilot clinical trial
H Abdelhakim, A Accurso, D Merkel… - Bone Marrow …, 2021 - nature.com
Graft-versus-host disease (GVHD) is a significant cause of morbidity and mortality among
patients undergoing hematopoietic stem cell transplantation (HSCT)[1, 2]. Patients with …
patients undergoing hematopoietic stem cell transplantation (HSCT)[1, 2]. Patients with …